Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study.

Iacono D, Fasano S, Pantano I, D'Abrosca V, Ruscitti P, Margiotta DPE, Navarini L, Maruotti N, Grembiale RD, Cantatore FP, Afeltra A, Giacomelli R, Valentini G.

Cardiol Res Pract. 2019 May 2;2019:2748035. doi: 10.1155/2019/2748035. eCollection 2019.

2.

Observational study on the QUality of life of Italian Axial SpondyloARthritis patients (QUASAR): baseline data.

D'Angelo S, Gilio M, D'Attino RM, Gualberti G, Merolla R, di Luzio Paparatti U, Malavolta N, Corvaglia S, Marchetta A, Scambi C, Romeo N, Pettiti G, Salvarani C, Catanoso MG, Scarpa R, Costa L, Ramonda R, Frallonardo P, Muratore M, Quarta L, Passiu G, Erre GL, Lubrano D, Tirri E, Govoni M, Furini F, Russo R, Buono R, Pozzi MR, Riva M, Grembiale RD, Bruno C, Gibertini P, Marchesoni A.

Clin Exp Rheumatol. 2019 Apr 2. [Epub ahead of print]

PMID:
30943145
3.

Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study.

Macchioni P, Salvarani C, Possemato N, Gutierrez M, Grassi W, Gasparini S, Perricone C, Perrotta FM, Grembiale RD, Bruno C, Tripolino C, Govoni M, Ciancio G, Farina I, Ramonda R, Frallonardo P, Desiati F, Scarpa R, Costa L, Zabotti A, De Vita S, D'Attino RM, Gualberti G, Merolla R, di Luzio Paparatti U, Aldigeri R, Marchesoni A.

J Rheumatol. 2019 Aug;46(8):904-911. doi: 10.3899/jrheum.171411. Epub 2019 Mar 15.

4.

Lipid Oxidation Assessed by Indirect Calorimetry Predicts Metabolic Syndrome and Type 2 Diabetes.

Pujia A, Mazza E, Ferro Y, Gazzaruso C, Coppola A, Doldo P, Grembiale RD, Pujia R, Romeo S, Montalcini T.

Front Endocrinol (Lausanne). 2019 Jan 10;9:806. doi: 10.3389/fendo.2018.00806. eCollection 2018.

5.

Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP).

Palleria C, Iannone L, Leporini C, Citraro R, Manti A, Caminiti M, Gigliotti P, Grembiale RD, L'Andolina M, Muccari G, Naturale MD, Olivo D, Pagano Mariano G, Pellegrini R, Varcasia G, Abdalla K, Russo E, Ursini F, De Sarro G.

PLoS One. 2018 Oct 24;13(10):e0205134. doi: 10.1371/journal.pone.0205134. eCollection 2018.

6.

Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literature.

Ruscitti P, Sinigaglia L, Cazzato M, Grembiale RD, Triolo G, Lubrano E, Montecucco C, Giacomelli R.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii23-vii31. doi: 10.1093/rheumatology/key132. Review.

PMID:
30289540
7.

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence.

Iacono D, Favoino E, Borgia A, Fasano S, Pantano I, D'Abrosca V, Picillo G, Grembiale RD, Perosa F, Valentini G.

Open Access Rheumatol. 2018 Sep 6;10:129-134. doi: 10.2147/OARRR.S163731. eCollection 2018.

8.

Mouse models of multiple myeloma: technologic platforms and perspectives.

Rossi M, Botta C, Arbitrio M, Grembiale RD, Tagliaferri P, Tassone P.

Oncotarget. 2018 Apr 13;9(28):20119-20133. doi: 10.18632/oncotarget.24614. eCollection 2018 Apr 13. Review.

9.

Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.

Ruscitti P, Iacono D, Ciccia F, Emmi G, Cipriani P, Grembiale RD, Perosa F, Emmi L, Triolo G, Giacomelli R, Valentini G.

J Rheumatol. 2018 Jun;45(6):864-872. doi: 10.3899/jrheum.170955. Epub 2018 Apr 15.

PMID:
29657144
10.

Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-Control Study.

Ursini F, D Angelo S, Russo E, Ammerata G, Abenavoli L, Mauro D, Bruno C, Naty S, Grembiale RD, Olivieri I, De Sarro G.

Rev Recent Clin Trials. 2018;13(3):215-221. doi: 10.2174/1574887113666180314092757.

PMID:
29542421
11.

Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Leporini C, Russo E, D Angelo S, Arturi F, Tripepi G, Peluso R, Grembiale RD, Olivieri I, De Sarro G, Ursini F.

Rev Recent Clin Trials. 2018;13(3):184-191. doi: 10.2174/1574887113666180314100340.

PMID:
29542420
12.

Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study.

Ursini F, Russo E, Mauro D, Abenavoli L, Ammerata G, Serrao A, Grembiale RD, De Sarro G, Olivieri I, D'angelo S.

Eur J Clin Invest. 2017 Oct;47(10):728-735. doi: 10.1111/eci.12798. Epub 2017 Sep 2.

PMID:
28796299
13.

Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis.

Ursini F, Leporini C, Bene F, D'Angelo S, Mauro D, Russo E, De Sarro G, Olivieri I, Pitzalis C, Lewis M, Grembiale RD.

Sci Rep. 2017 Jul 13;7(1):5346. doi: 10.1038/s41598-017-05759-2.

14.

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.

Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG.

Autoimmun Rev. 2017 Sep;16(9):911-924. doi: 10.1016/j.autrev.2017.07.012. Epub 2017 Jul 11. Review.

PMID:
28705780
15.

Role of Positron Emission Tomography for Central Nervous System Involvement in Systemic Autoimmune Diseases: Status and Perspectives.

Mauro D, Barbagallo G, D Angelo S, Sannino P, Naty S, Bruno C, Olivieri I, Grembiale RD, Ursini F.

Curr Med Chem. 2018;25(26):3096-3104. doi: 10.2174/0929867324666170523144402. Review.

PMID:
28545366
16.

Plantar fascia enthesopathy is highly prevalent in diabetic patients without peripheral neuropathy and correlates with retinopathy and impaired kidney function.

Ursini F, Arturi F, Nicolosi K, Ammendolia A, D'Angelo S, Russo E, Naty S, Bruno C, De Sarro G, Olivieri I, Grembiale RD.

PLoS One. 2017 Mar 30;12(3):e0174529. doi: 10.1371/journal.pone.0174529. eCollection 2017.

17.

Old But Good: Modified-Release Prednisone in Rheumatoid Arthritis.

Ursini F, Naty S, Bruno C, Grembiale RD.

Rev Recent Clin Trials. 2017;12(2):124-128. doi: 10.2174/1574887112666170328124539. Review.

PMID:
28356031
18.

Kaposi's sarcoma after T-cell costimulation blockade with abatacept in rheumatoid arthritis: a case report.

Olivo D, Grembiale RD, Tallarigo F, Russo E, De Sarro G, Ursini F.

J Clin Pharm Ther. 2017 Jun;42(3):367-369. doi: 10.1111/jcpt.12510. Epub 2017 Mar 6.

PMID:
28262965
19.

Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis.

Ursini F, D'Angelo S, Russo E, Arturi F, D'Antona L, Bruno C, Naty S, De Sarro G, Olivieri I, Grembiale RD.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):18-23. Epub 2016 Oct 27.

PMID:
27908300
20.

High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy.

Ursini F, Arturi F, D'Angelo S, Amara L, Nicolosi K, Russo E, Naty S, Bruno C, De Sarro G, Olivieri I, Grembiale RD.

J Am Podiatr Med Assoc. 2017 Mar;107(2):99-105. doi: 10.7547/16-059. Epub 2016 Oct 10.

PMID:
27723381
21.

Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis.

Ursini F, D'Angelo S, Russo E, Nicolosi K, Gallucci A, Chiaravalloti A, Bruno C, Naty S, De Sarro G, Olivieri I, Grembiale RD.

PLoS One. 2016 Sep 22;11(9):e0163464. doi: 10.1371/journal.pone.0163464. eCollection 2016.

22.

Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on "Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study" by Tseng et al., Joint Bone Spine 2016;83:307-13.

Ursini F, D'Angelo S, Padula A, Gilio M, Russo E, Naty S, De Sarro G, Grembiale RD, Olivieri I.

Joint Bone Spine. 2016 Oct;83(5):611-2. doi: 10.1016/j.jbspin.2016.07.006. Epub 2016 Sep 9. No abstract available.

PMID:
27622312
23.

Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis.

Ursini F, Grembiale RD, D'Antona L, Gallo E, D'Angelo S, Citraro R, Visca P, Olivieri I, De Sarro G, Perrotti N, Russo E.

J Invest Dermatol. 2016 Sep;136(9):1892-1894. doi: 10.1016/j.jid.2016.05.097. Epub 2016 May 29. No abstract available.

24.

Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study.

Ursini F, Russo E, D'Angelo S, Arturi F, Hribal ML, D'Antona L, Bruno C, Tripepi G, Naty S, De Sarro G, Olivieri I, Grembiale RD.

Medicine (Baltimore). 2016 Feb;95(7):e2552. doi: 10.1097/MD.0000000000002552.

25.

Correlation between elastosonography and nailfold microvascular alterations in systemic sclerosis patients.

Grembiale RD, Bruno C, Tripolino C, Ursini F, Calabria M, Naty S, Gutierrez M, Mazzuca S.

Clin Hemorheol Microcirc. 2016;62(1):71-8. doi: 10.3233/CH-151948.

PMID:
26410857
26.

Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study.

Ursini F, Russo E, Letizia Hribal M, Mauro D, Savarino F, Bruno C, Tripolino C, Rubino M, Naty S, Grembiale RD.

Medicine (Baltimore). 2015 May;94(21):e888. doi: 10.1097/MD.0000000000000888.

27.

Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy.

Ursini F, Russo E, Leporini C, Calabria M, Bruno C, Tripolino C, Naty S, Grembiale RD.

Case Rep Rheumatol. 2015;2015:614504. doi: 10.1155/2015/614504. Epub 2015 Feb 10.

28.

Use of Sonoelastography to Evaluate Texture Modifications of Mozzarella di Bufala Campana Protected Designation of Origin During Storage at Different Temperatures.

Costanzo N, Santoro AM, Sarno E, Di Loria A, Grembiale RD, Britti D, Capuano F.

Ital J Food Saf. 2014 Oct 9;4(4):4746. eCollection 2015 Nov 2.

29.

Abatacept in psoriatic arthritis: Case report and short review.

Ursini F, Naty S, Russo E, Grembiale RD.

J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S29-32. doi: 10.4103/0976-500X.120943.

30.

Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients.

Ursini F, Grembiale A, Naty S, Grembiale RD.

Clin Rheumatol. 2014 Dec;33(12):1759-64. doi: 10.1007/s10067-013-2366-4. Epub 2013 Sep 5.

PMID:
24005838
31.

Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis.

Patanè M, Ciriaco M, Chimirri S, Ursini F, Naty S, Grembiale RD, Gallelli L, De Sarro G, Russo E.

Adv Pharmacol Sci. 2013;2013:313858. doi: 10.1155/2013/313858. Epub 2013 May 12.

32.

Improvement in insulin resistance after short-term treatment with abatacept: case report and short review.

Ursini F, Mauro D, Naty S, Gagliardi D, Grembiale RD.

Clin Rheumatol. 2012 Sep;31(9):1401-2. doi: 10.1007/s10067-012-2034-0. Epub 2012 Jul 27. Review.

PMID:
22837017
33.

Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma.

Pelaia G, Gallelli L, Romeo P, Renda T, Busceti MT, Proietto A, Grembiale RD, Marsico SA, Maselli R, Vatrella A.

Int J Clin Pharmacol Ther. 2011 Dec;49(12):713-21.

PMID:
22122813
34.

Update on optimal use of omalizumab in management of asthma.

Pelaia G, Gallelli L, Renda T, Romeo P, Busceti MT, Grembiale RD, Maselli R, Marsico SA, Vatrella A.

J Asthma Allergy. 2011;4:49-59. doi: 10.2147/JAA.S14520. Epub 2011 Jun 13.

35.

Fibromyalgia and obesity: the hidden link.

Ursini F, Naty S, Grembiale RD.

Rheumatol Int. 2011 Nov;31(11):1403-8. doi: 10.1007/s00296-011-1885-z. Epub 2011 Apr 8. Review.

PMID:
21476098
36.

Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab.

Ursini F, Succurro E, Grembiale A, Rudi S, Grembiale RD, Arturi F.

Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):961-3.

PMID:
20943070
37.

Efficacy and safety of duloxetine in fibromyalgia.

Ursini F, Pipicelli G, Grembiale RD.

Clin Ter. 2010;161(4):391-5. Review.

PMID:
20931165
38.

Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab.

Ursini F, Naty S, Mazzei V, Spagnolo F, Grembiale RD.

Int Immunopharmacol. 2010 Jul;10(7):827-8. doi: 10.1016/j.intimp.2010.04.016. Epub 2010 Apr 28. No abstract available.

PMID:
20433950
39.

Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients.

Sciacqua A, Perticone M, Miceli S, Laino I, Tassone EJ, Grembiale RD, Andreozzi F, Sesti G, Perticone F.

Nutr Metab Cardiovasc Dis. 2011 Jul;21(7):485-91. doi: 10.1016/j.numecd.2009.11.015. Epub 2010 Mar 12.

PMID:
20227260
40.

CD4+ T-cells lymphocytosis and reduction of neutrophils during treatment with adalimumab: Challenge and dechallenge study.

Ursini F, Naty S, Bruno C, Calabria M, Spagnolo F, Grembiale RD.

Clin Immunol. 2010 Jun;135(3):499-500. doi: 10.1016/j.clim.2010.02.004. Epub 2010 Mar 12. No abstract available.

PMID:
20219434
41.

Infliximab and insulin resistance.

Ursini F, Naty S, Grembiale RD.

Autoimmun Rev. 2010 Jun;9(8):536-9. doi: 10.1016/j.autrev.2009.12.014. Epub 2010 Jan 7. Review.

PMID:
20060507
42.

Effect of interaction between left ventricular dysfunction and endothelial function in hypertension.

Sciacqua A, Borrello F, Vatrano M, Grembiale RD, Perticone F.

Curr Hypertens Rep. 2006 Jun;8(3):212-8. Review.

PMID:
17147919
43.

Oxidative stress and lung diseases.

Maselli R, Grembiale RD, Pelaia G, Cuda G.

Monaldi Arch Chest Dis. 2002 Jun-Aug;57(3-4):180-1. Review.

PMID:
12619379
44.

Effects of transforming growth factor-[beta] and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells.

Pelaia G, Cuda G, Vatrella A, Fratto D, Grembiale RD, Tagliaferri P, Maselli R, Costanzo FS, Marsico SA.

Am J Respir Cell Mol Biol. 2003 Jul;29(1):12-8. Epub 2003 Jan 10.

PMID:
12600835
45.

Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients.

Grembiale RD, Pelaia G, Naty S, Vatrella A, Tranfa CM, Marsico SA.

Pulm Pharmacol Ther. 2002;15(5):463-6.

PMID:
12406669
46.

Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease.

Pelaia G, Gallelli L, Vatrella A, Grembiale RD, Maselli R, De Sarro GB, Marsico SA.

Life Sci. 2002 Jan 18;70(9):977-90. Review.

PMID:
11862989
47.

Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells.

Pelaia G, Cuda G, Vatrella A, Grembiale RD, De Sarro G, Maselli R, Costanzo FS, Avvedimento VE, Rotiroti D, Marsico SA.

Biochem Pharmacol. 2001 Dec 15;62(12):1719-24.

PMID:
11755126
48.

Bronchial asthma induced by an antithyroid drug.

Grembiale RD, Naty S, Iorio C, Crispino N, Pelaia G, Tranfa CM.

Chest. 2001 May;119(5):1598-9.

PMID:
11348974
49.

Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness.

Grembiale RD, Camporota L, Naty S, Tranfa CM, Djukanovic R, Marsico SA.

Am J Respir Crit Care Med. 2000 Dec;162(6):2048-52.

PMID:
11112112
50.

Short-term cardiovascular effects of salmeterol.

Tranfa CM, Pelaia G, Grembiale RD, Naty S, Durante S, Borrello G.

Chest. 1998 May;113(5):1272-6.

PMID:
9596305

Supplemental Content

Loading ...
Support Center